Child Neurology: Reversible Dementia in an 18-Year-Old Woman Due to Undiagnosed Cobalamin-G Deficiency: A Case Report

Anthony M Gacita1, Alma Bicknese1, Katherine Kim1

  • 1From the Department of Genetics, Genomics, and Metabolism (A.M.G., K.K., J.B.), Department of Neurology (A.B.), and Department of Psychiatry and Behavioral Health (F.Z.), Ann & Robert H. Lurie Children's Hospital of Chicago, IL.

Neurology
|February 16, 2023
PubMed

Insights

Cobalamin-G deficiency, a vitamin B12 metabolism disorder, can manifest later in life with dementia. Early diagnosis and treatment with B12 can reverse cognitive decline.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Cobalamin-G deficiency is an inherited metabolic disorder affecting vitamin B12 utilization in the remethylation pathway.
  • Classic presentation involves early-onset anemia, developmental delay, and metabolic crisis.

Observation:

  • A late-onset phenotype of Cobalamin-G deficiency was observed in an 18-year-old female.
  • Symptoms included progressive dementia, encephalopathy, epilepsy, and functional regression over 4 years.
  • Initial metabolic screening was normal.

Findings:

  • Whole-exome sequencing revealed pathogenic variants in the MTR gene, suggesting Cobalamin-G deficiency.
  • Subsequent biochemical testing confirmed the diagnosis.
  • Treatment with leucovorin, betaine, and vitamin B12 injections led to cognitive recovery.

Implications:

  • This case expands the known phenotypic spectrum of Cobalamin-G deficiency to include late-onset neuropsychiatric presentations.
  • Highlights the importance of considering genetic and metabolic testing for dementia in adolescents.
  • Suggests potential for therapeutic intervention even in later-presenting cases.

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
860
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
217
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
591
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
151
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
235
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
175